Fundz

Meddenovo Drug Design raised €1M in a Pre-Seed funding round led by ACT Venture Partners to innovate drug design using cyclic peptides and AI technology.

PRIVATEAug 02, 2024

Amount Raised

€1 Million

Round Type

Pre-Seed

LyonBiotechnologyArtificial IntelligencePharmaceutical

Investors

ACT Venture Partners

Description

Meddenovo Drug Design has completed a Pre-Seed investment round, raising up to €1 million. The funding will be used to enhance R&D and accelerate the development of effective therapies for various diseases.

Quick answer

Meddenovo Drug Design raised €1 Million in a Pre-Seed round, dated August 2, 2024. Investors: ACT Venture Partners. Meddenovo Drug Design is based in Lyon, Auvergne Rhône Alpes, France.

How much did Meddenovo Drug Design raise?
Meddenovo Drug Design raised €1 Million in a Pre-Seed round on August 2, 2024.
Who invested in Meddenovo Drug Design?
ACT Venture Partners is named as investors in this round.
What does Meddenovo Drug Design do?
Meddenovo is at the forefront of AI-driven drug discovery, pioneering a specialized technology platform designed specifically for cyclic peptides.
Where is Meddenovo Drug Design based and how big is it?
Meddenovo Drug Design is based in Lyon, Auvergne Rhône Alpes, France.
Who are the decision-makers at Meddenovo Drug Design?
Fundz holds 1 contact at Meddenovo Drug Design. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Meddenovo Drug Design, and when

A new round usually means Meddenovo Drug Design is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Meddenovo Drug Design raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Meddenovo Drug Design, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Meddenovo Drug Design. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Meddenovo Drug Design

Location

Lyon, Auvergne Rhône Alpes, France

About

Meddenovo is at the forefront of AI-driven drug discovery, pioneering a specialized technology platform designed specifically for cyclic peptides. Our innovative approach leverages a unique blend of AI technologies and molecular modeling to significantly enhance the efficiency and success rates of drug development processes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Meddenovo Drug Design raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Meddenovo Drug Design's next move

See what Strategic adds

Meddenovo Drug Design raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.